100
Participants
Start Date
June 1, 2018
Primary Completion Date
October 20, 2022
Study Completion Date
November 11, 2022
Tennant Biomodulator ®
Tennant Biomodulator ® (Avazzia, Inc., Texas, USA)(FDA Classification: 882.5890 Neurology, Biofeedback device) is FDA-cleared for symptomatic relief and management of chronic pain. The device is simply activated using device buttons and does not need to be adjusted or monitored once therapy begins, making it easy for the purpose of therapy under unsupervised conditions or for use in busy HD clinics. The device will be used with FDA-cleared TENS electrodes that will be connected to the device via wires, providing an electrically conductive interface between the device and the subject's skin.
RECRUITING
Hamad Medical Corporation, Doha
ACTIVE_NOT_RECRUITING
Baylor College of Medicine, USA, Houston
Lead Sponsor
Qatar National Research Fund
OTHER
Baylor College of Medicine
OTHER
Hamad Medical Corporation
INDUSTRY